Jiagen Wen

1.6k total citations
47 papers, 1.1k citations indexed

About

Jiagen Wen is a scholar working on Molecular Biology, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, Jiagen Wen has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Nephrology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Jiagen Wen's work include Acute Kidney Injury Research (9 papers), Chronic Kidney Disease and Diabetes (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jiagen Wen is often cited by papers focused on Acute Kidney Injury Research (9 papers), Chronic Kidney Disease and Diabetes (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). Jiagen Wen collaborates with scholars based in China, United States and Saint Kitts and Nevis. Jiagen Wen's co-authors include Xiao‐Ming Meng, Xue‐qi Liu, Ling Jiang, Li Gao, Hong‐Hao Zhou, Wei Zhang, Qin Yang, Jian‐Quan Luo, Jianan Wang and Yonggui Wu and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiagen Wen

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiagen Wen China	19	515	211	145	121	117	47	1.1k
Chunling Huang China	21	565 1.1×	200 0.9×	92 0.6×	162 1.3×	118 1.0×	56	1.1k
Haijiang Wu China	18	612 1.2×	220 1.0×	153 1.1×	148 1.2×	95 0.8×	27	1.1k
Xia Zhong China	19	423 0.8×	158 0.7×	122 0.8×	198 1.6×	93 0.8×	42	1.1k
Xue‐qi Liu China	21	657 1.3×	330 1.6×	166 1.1×	146 1.2×	141 1.2×	33	1.2k
Chen Yu China	23	498 1.0×	358 1.7×	189 1.3×	96 0.8×	186 1.6×	82	1.4k
Ruizhi Tan China	21	716 1.4×	340 1.6×	179 1.2×	133 1.1×	149 1.3×	73	1.4k
Rong Wang China	22	482 0.9×	441 2.1×	229 1.6×	86 0.7×	124 1.1×	71	1.3k
Xiaowen Yu China	19	440 0.9×	138 0.7×	139 1.0×	119 1.0×	96 0.8×	46	1.1k
Zhigang Zhang China	17	717 1.4×	448 2.1×	135 0.9×	131 1.1×	104 0.9×	64	1.5k

Countries citing papers authored by Jiagen Wen

Since Specialization

Citations

This map shows the geographic impact of Jiagen Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiagen Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiagen Wen more than expected).

Fields of papers citing papers by Jiagen Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiagen Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiagen Wen. The network helps show where Jiagen Wen may publish in the future.

Co-authorship network of co-authors of Jiagen Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Jiagen Wen. A scholar is included among the top collaborators of Jiagen Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiagen Wen. Jiagen Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiangyu, Xiaoyu Shen, Yuqing Wang, et al.. (2025). PARylation promotes acute kidney injury via RACK1 dimerization-mediated HIF-1α degradation. Acta Pharmaceutica Sinica B. 15(9). 4673–4691. 1 indexed citations

Liu, Dong, C. P. Chu, Yueyue Wang, et al.. (2025). Vaccarin alleviates renal ischemia-reperfusion injury by inhibiting inflammation and ferroptosis. International Immunopharmacology. 153. 114463–114463. 1 indexed citations

Yu, Ju-tao, Xiangyü Li, Rui Hou, et al.. (2023). Novel insights into STAT3 in renal diseases. Biomedicine & Pharmacotherapy. 165. 115166–115166. 12 indexed citations

Wu, Tingni, Shiqing Chen, Qin Yang, et al.. (2023). Vaccarin alleviates cisplatin-induced acute kidney injury via decreasing NOX4-derived ROS. Heliyon. 9(11). e21231–e21231. 11 indexed citations

Jiang, Ling, Xue‐qi Liu, Li Gao, et al.. (2022). METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy. Molecular Therapy. 30(4). 1721–1740. 135 indexed citations

Gong, Qian, Fang Wang, Xiaowen Feng, et al.. (2022). Protective effect of inhibiting necroptosis on gentamicin‐induced nephrotoxicity. The FASEB Journal. 36(9). e22487–e22487. 7 indexed citations

Suo, Xiao-Guo, Fang Wang, Xiaoyan He, et al.. (2022). Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis. European Journal of Pharmacology. 929. 175116–175116. 8 indexed citations

He, Yuan, Qin Yang, Chao Li, et al.. (2022). Cpd-0225 attenuates renal fibrosis via inhibiting ALK5. Biochemical Pharmacology. 204. 115240–115240. 3 indexed citations

Jin, Juan, Yaru Yang, Qian Gong, et al.. (2022). Role of epigenetically regulated inflammation in renal diseases. Seminars in Cell and Developmental Biology. 154(Pt C). 295–304. 3 indexed citations

10.

Jiang, Wei, Jiarong Wang, Xin Jiao, et al.. (2021). Caveolin-1 attenuates acetaminophen aggravated lipid accumulation in alcoholic fatty liver by activating mitophagy via the Pink-1/Parkin pathway. European Journal of Pharmacology. 908. 174324–174324. 18 indexed citations

11.

Li, Chao, Ying Chen, Yuan He, et al.. (2021). The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKI. Frontiers in Medicine. 8. 796724–796724. 53 indexed citations

12.

Jiang, Wei, et al.. (2021). Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway. Frontiers in Pharmacology. 12. 717276–717276. 17 indexed citations

13.

Yang, Qin, Haiyong Chen, Jianan Wang, et al.. (2020). Alcohol promotes renal fibrosis by activating Nox2/4-mediated DNA methylation of Smad7. Clinical Science. 134(2). 103–122. 26 indexed citations

14.

Liu, Xue‐qi, Juan Jin, Zeng Li, et al.. (2020). Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy. Biochemical Pharmacology. 180. 114132–114132. 27 indexed citations

15.

Wang, Jianan, Qin Yang, Chen Yang, et al.. (2020). Smad3 promotes AKI sensitivity in diabetic mice via interaction with p53 and induction of NOX4-dependent ROS production. Redox Biology. 32. 101479–101479. 68 indexed citations

16.

Ji, Yaru, Yu Chen, Yanni Chen, et al.. (2020). Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5. International Immunopharmacology. 82. 106374–106374. 14 indexed citations

17.

Wen, Jiagen, Zhaoqian Liu, Hong‐Hao Zhou, et al.. (2018). The influence of telmisartan on metformin pharmacokinetics and pharmacodynamics. Journal of Pharmacological Sciences. 139(1). 37–41. 7 indexed citations

18.

Liu, Guojing, Jiagen Wen, Dong Guo, et al.. (2016). The effects of rabeprazole on metformin pharmacokinetics and pharmacodynamics in Chinese healthy volunteers. Journal of Pharmacological Sciences. 132(4). 244–248. 7 indexed citations

19.

Luo, Jian‐Quan, Jiagen Wen, Hong‐Hao Zhou, Xiaoping Chen, & Wei Zhang. (2014). Endothelial Nitric Oxide Synthase Gene G894T Polymorphism and Myocardial Infarction: A Meta-Analysis of 34 Studies Involving 21068 Subjects. PLoS ONE. 9(1). e87196–e87196. 38 indexed citations

20.

Chen, Yuxiang, et al.. (2012). A validated UV-HPLC method for determination of chlorogenic acid in Lepidogrammitis drymoglossoides (Baker) Ching, Polypodiaceae. Pharmacognosy Research. 4(3). 148–148. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact